Desogestrel-containing COCP Pharmacokinetic Validation Study
Status:
Not yet recruiting
Trial end date:
2022-02-01
Target enrollment:
Participant gender:
Summary
This study aims to validate prior pharmacokinetic research with combined oral contraceptive
pill users that supports utilizing a 24-hour trough concentration as an accurate proxy for
the intensive pharmacokinetic parameter of area under the curve (gold standard
pharmacokinetics). The original pharmacokinetic studies were performed with a
levonorgestrel-containing oral contraceptive pill and we aim to duplicate those findings with
a desogestrel-containing oral contraceptive pill.